Date:
A woman with aggressive refractory systemic lupus erythematosus was treated with a short course of the bispecific antibody teclistamab (anti–B-cell maturation antigen and anti-CD3) and had a drug-free complete remission.
The New England Journal of Medicine: Search Results in Allergy/Immunology
Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.
© 2021 tagDiv. All Rights Reserved. Made with Newspaper Theme.
